XML 14 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended
Sep. 30, 2013
Sep. 30, 2012
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Revenues $ 95 $ 195
Cost of revenues (3) (6)
Gross profit 92 189
Research and development expenses (5,497) (3,748)
Less participation by the Office of the Chief Scientist and other parties 2,374 1,050
Research and development expenses, net (3,123) (2,698)
General and administrative expenses (1,829) (1,681)
Total operating expenses (4,952) (4,379)
Operating loss (4,860) (4,190)
Financial income, net 105 195
Net loss $ (4,755) $ (3,995)
Loss per share:    
Basic and diluted net loss per share $ (0.08) $ (0.08)
Weighted average number of shares used in computing basic and diluted net loss per share 59,254,132 47,833,654